Cara Therapeutics | CARA - Equity Capital And Reserves

Stock Price
3.39
Daily Change
0.17 5.28%
Monthly
-1.45%
Yearly
-80.60%
Q2 Forecast
2.82

Cara Therapeutics reported $27.87M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Cara Therapeutics USD 27.87M 5.06M Sep/2025
Cassava Sciences USD 74.4M 7.16M Dec/2025
Chugai Pharma JPY 1.89T 95.02B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
J&J USD 81.54B 3.07B Dec/2025
Neurocrine Biosciences USD 3.25B 249.5M Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
RedHill Biopharma USD -4.41M 271K Jun/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Vanda Pharmaceuticals USD 327.19M 138.81M Dec/2025